Milligan John C.k. Iv - Net Worth and Insider Trading

Milligan John C.k. Iv Net Worth

The estimated net worth of Milligan John C.k. Iv is at least $208,069 dollars as of 2024-04-16. Milligan John C.k. Iv is the Secretary/CEO of subsidiary of TherapeuticsMD Inc and owns about 106,702 shares of TherapeuticsMD Inc (TXMD) stock worth over $208,069. Details can be seen in Milligan John C.k. Iv's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Milligan John C.k. Iv has not made any transactions after 2021-05-11 and currently still holds the listed stock(s).

Transaction Summary of Milligan John C.k. Iv

To

Milligan John C.k. Iv Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Milligan John C.k. Iv owns 1 companies in total, including TherapeuticsMD Inc () .

Click here to see the complete history of Milligan John C.k. Iv’s form 4 insider trades.

Insider Ownership Summary of Milligan John C.k. Iv

Ticker Comapny Transaction Date Type of Owner
TherapeuticsMD Inc 2021-05-11 director & 10 percent owner & President & Secretary & Director

Milligan John C.k. Iv Latest Holdings Summary

Milligan John C.k. Iv currently owns a total of 1 stock. Milligan John C.k. Iv owns 106,702 shares of TherapeuticsMD Inc (TXMD) as of May 11, 2021, with a value of $208,069.

Latest Holdings of Milligan John C.k. Iv

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TXMD TherapeuticsMD Inc 2021-05-11 106,702 1.95 208,069

Holding Weightings of Milligan John C.k. Iv


Milligan John C.k. Iv Form 4 Trading Tracker

According to the SEC Form 4 filings, Milligan John C.k. Iv has made a total of 5 transactions in TherapeuticsMD Inc (TXMD) over the past 5 years, including 4 buys and 1 sells. The most-recent trade in TherapeuticsMD Inc is the sale of 885 shares on May 11, 2021, which brought Milligan John C.k. Iv around $46,022.

Insider Trading History of Milligan John C.k. Iv

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Milligan John C.k. Iv Trading Performance

GuruFocus tracks the stock performance after each of Milligan John C.k. Iv's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Milligan John C.k. Iv is -9.41%. GuruFocus also compares Milligan John C.k. Iv's trading performance to market benchmark return within the same time period. The performance of stocks bought by Milligan John C.k. Iv within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Milligan John C.k. Iv's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Milligan John C.k. Iv

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 5.7 -9.41 -41.05 -45.94 -47.28 -62.23
Relative Return to S&P 500(%) 1.81 -17.75 -46.54 -61.76 -70.91 -73.54

Milligan John C.k. Iv Ownership Network

Ownership Network List of Milligan John C.k. Iv

No Data

Ownership Network Relation of Milligan John C.k. Iv


Milligan John C.k. Iv Owned Company Details

What does TherapeuticsMD Inc do?

Who are the key executives at TherapeuticsMD Inc?

Milligan John C.k. Iv is the director & 10 percent owner & President & Secretary & Director of TherapeuticsMD Inc. Other key executives at TherapeuticsMD Inc include General Counsel Marlan D Walker , Principal Financial Officer Joseph Ziegler , and CAO and VP of Finance Michael C Donegan .

TherapeuticsMD Inc () Insider Trades Summary

Over the past 18 months, Milligan John C.k. Iv made no insider transaction in TherapeuticsMD Inc (). Other recent insider transactions involving TherapeuticsMD Inc () include a net sale of 21,960 shares made by Marlan D Walker , a net sale of 3,916 shares made by Michael C Donegan , and a net purchase of 35,238 shares made by Rubric Capital Management Lp .

In summary, during the past 3 months, insiders sold 0 shares of TherapeuticsMD Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 31,493 shares of TherapeuticsMD Inc () were sold and 35,238 shares were bought by its insiders, resulting in a net purchase of 3,745 shares.

TherapeuticsMD Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TherapeuticsMD Inc Insider Transactions

No Available Data

Milligan John C.k. Iv Mailing Address

Above is the net worth, insider trading, and ownership report for Milligan John C.k. Iv. You might contact Milligan John C.k. Iv via mailing address: 951 Broken Sound Parkway Nw, Suite 320, Boca Raton Fl 33487.

Discussions on Milligan John C.k. Iv

No discussions yet.